HighTower Advisors’s Zymeworks ZYME Stock Holding History

HighTower Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$944K	Sell	36,100 -162	-0.4%	-$4.12K	﹤0.01%	2272
2026 Q1	$908K	Buy	+36,262	New	+$858K	﹤0.01%	2252

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

HighTower Advisors's ZYME Position: Q2 2026 in Review

HighTower Advisors reduced its Zymeworks (ZYME) stake by 0.45% in Q2 2026, selling an estimated $4.12K and leaving 36,100 shares worth $944K. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

HighTower Advisors first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

HighTower Advisors held 36,100 shares of Zymeworks worth $944K as of Q2 2026.
HighTower Advisors sold 162 Zymeworks shares in Q2 2026, an estimated $4.12K.
Zymeworks made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2272 holding.
HighTower Advisors first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.